FIELD: medicine.
SUBSTANCE: method involves controlling the patient's state, wherein the blood troponin I concentration is measured initially and every 60 minutes after the beginning of thrombolysis up to 4 hours, and if observing the troponin I concentration in 10 times and more as compared to the previous value, the thrombolytic therapy is considered to be effective. The invention can be used in acute cardiology for assessing the efficacy of the thrombolytic therapy in the patients with acute myocardial infarction with ST-segment elevation and enables assessing the efficacy of the thrombolytic therapy over a short period of time and to high precision. Recurrent infarctions in past medical history, intervention cardiac procedures and cardiac surgeries have no effect on the findings.
EFFECT: higher assessment accuracy.
3 dwg, 2 tbl, 3 ex
